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We examined the methodological approach to the assessment of monosodium glutamate intake. The high
carbohydrate and low fat consumption characteristic of this study population would be conducive to the development
of metabolic syndrome. However, anomalies in the assessment of dietary information limits conclusion to a causal link
of monosodium glutamate to metabolic syndrome and overweight because the study lacks data on the main dietary
patterns of consumption. Given the current paucity of data from human studies on monosodium glutamate intake
and risk, more studies with robust methodology are required to assess causal links to disease.
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Dear Editor,
The paper by Insawang et al., concerning monosodium
glutamate (MSG) intake and its association with meta-
bolic syndrome (Met-S) in a rural Thai population is the
centre of a current debate [1-3]. They estimated for
every 1 g increase in MSG consumption, Met-S risk in-
creased with an odds ratio (OR) of 1.14 (CI 1.12-1.28) or
being overweight with an OR of 1.16 (CI 1.04-1.29).
Was the novel approach in assessment of MSG justified?
The ability of cognitive recall to capture accurately
micro-quantities of substances in the food chain is sub-
ject to interpretation error. The InterMap Study
reported a mean intake of 0.33 g/day by participants
demonstrating the amount of MSG used in food prepar-
ation which was then weighed [4]. In the China Health
and Nutrition Survey the MSG container was weighed
before cooking started and at the end of the day, yielding
an estimate of 1.8 g/day [5]. MSG consumption of 3.8 g/
day in the Jiangsu Nutrition Study (JNS) was estimated
from total monthly consumption reported per household
divided by the number of residents and adjusted by* Correspondence: tilly_karu@yahoo.co.uk
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distribution, and reproduction in any mediumproportion of household energy intake for each individ-
ual [6]. In these 3 studies, assessment for total glutamate
content included both direct and indirect sources [4-6].
Insawang et al. provided each household a 250 g box
of MSG and difference in box weight from the last (10th
day) to the 1st day was assumed to be the quantity of
MSG consumed after factoring in household number av-
eraged over the number of days (g/person/day) [1]. This
method would be an adaptation of the food disappear-
ance approach [7]. This term, as defined by the USDA-
ERS, means difference between beginning inventories
and ending food stocks [8]. Using supermarket shopping
receipts to assess food supply coming into a household
or even the method of monitoring stocks by store-
keepers are similar adaptations [9,10]. The possibility of
random error would exist because of the exclusion of
subjects ≤ 10 years from the count (overestimation), if
leftovers and food are given away (overestimation), lim-
ited number of assessment days, and lack of accounting
for ‘hidden’ sources of MSG (underestimation). A further
possibility is systematic error rising from subject bias as
the MSG product was given free raising a core question-
were the participants using ‘higher than normal’ amounts
of MSG in cooking? However, to satisfactorily establish a
causal diet-disease relation, evidence must be examined
from a variety of sources and congruence between these
sources achieved [11].d Central Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
Chinna and Karupaiah Nutrition & Metabolism 2013, 10:52 Page 2 of 3
http://www.nutritionandmetabolism.com/content/10/1/52Was the research question adequately addressed?
Two anomalies in the reported nutrient intake data are
present:
i. About 66.2% of subjects were engaging in vigorously
active lifestyle with a median consumption of 2032
kcal comprising ~66% carbohydrate and ~14.7% fat
calories and this pattern was consistent at the
highest tertile of MSG intake (68% carbohydrate and
14.1% fat calories). Direct conversion of
macronutrients to calories at the highest tertile
indicates carbohydrate consumption reaching ~71%
calories. The high carbohydrate and low fat
consumption characteristic for this population
typifies Pattern 4 diet of nutrition transition taking
place in developing countries, which despite a high-
activity profile and lean body phenotype would be
conducive to the development of Met-S [12]. These
dietary factors with causal links to MET-S were not
adjusted as confounding factors in the final analysis
[1]. The JNS study demonstrated, after adjusting for
either rice intake or dietary patterns, no association
between MSG intake and weight gain could be
found [6].
ii. Systematic error is probable in the dietary
assessment. The number of subjects with BMI >25
kg/m2 was increasing significantly across tertiles
(p=0.021) but yet caloric intake did not reflect this
trend suggesting underreporting [1]. MSG use is
related to its pleasurable taste sensation [13]. Obese
women have been shown to have lower taste
sensitivity for MSG and therefore prefer higher
concentrations than normal weight women [14].
Was statistical interpretation correct?
The presentation of statistics data for OR and confidence
intervals (CI) for study outputs as reported by the
Insawang et al. in Table two is misleading [1]. The title of
their table cited OR for MSG intake with insulin resist-
ance, overweight and Met-S as predictors. Yet overweight
and Met-S were identified as significant predictors of
MSG. This is totally wrong. MSG depends on Met-S or is
it vice versa?
What is the significance of OR? The problem was the
way the statistical information was presented by Insawang
et al. [1]. It is true that if the exposure (MSG intake) and
the outcome (having metabolic syndrome) are both di-
chotomous, an OR value of 1.14 (95% CI 1.12 - 1.28) is
very close to one and of hardly any clinical relevance. It is
also true that with a big sample size even a small OR will
be significant. However, if the predictor is a continuous
variable and the outcome is categorical, an OR value of
more than zero indicates an increased risk. If this is the
case, then we accept that the lower limit of 1.14 is anindication of increasing risk. This argument will be the
same for the outcome of being overweight (odds ratio
1.16, 95% CI 1.04 - 1.29).
Conclusions
Methodological limitations in the study relate to the as-
sessment of MSG and dietary macronutrients as well as
the interpretation of the clinical relevance of MSG ex-
posure to outcomes. The direction of animal studies link
MSG-linked obesity to Met-S, diabetes and liver disease
[15,16]. Therefore more human studies are needed to
explain a cause-effect relationship and mechanisms of
action as to whether MSG causes weight gain and insu-
lin resistance separate from the larger macronutrient
matrix and lifestyle factors. Given these loose threads of
evidence the spirit of scientific enquiry should persist, as
evidenced from the developmental pathways of animal
to human studies establishing trans fatty acids as a risk
factor for cardiovascular disease [17,18].
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